Reinald Pamplona Gras
Grau: Doctor/a
973 702 442
reinald.pamplona(ELIMINAR)@udl.cat
ResearcherID: http://www.researcherid.com/rid/A-7359-2010
Publicacions
-
Sánchez E; Sánchez M; Betriu À; Rius F; Torres G; Purroy F; Pamplona R; Ortega M; López-Cano C; Hernández M; Bueno M; Fernández E; Salvador J; Lecube A
Are Obesity Indices Useful for Detecting Subclinical Atheromatosis in a Middle-Aged Population?
Obesity Facts 13 1-11. .
-
Torres, P; Cacabelos, D; Pairada, J; Bauer, KC; Boada, J; Fontdevila, L; Rossi, C; Povedano, M; Ferrer, I; Pamplona, R; Finlay, BB; Portero-Otin, M; Ayala, V
Gender-Specific Beneficial Effects of Docosahexaenoic Acid Dietary Supplementation in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice.
NEUROTHERAPEUTICS 17 269-281. .
-
Yin, XY; Willinger, CM; Keefe, J; Liu, J; Fernandez-Ortiz, A; Ibáñez B; Peñalvo J; Adourian, A; Chen, G; Corella, D; Pamplona, R; Portero-Otin, M; Jove, M; Courchesne, P; van Duijn, CM; Fuster, V; Ordovas, JM; Demirkan, A; Larson, MG; Levy, D
Lipidomic profiling identifies signatures of metabolic risk.
EBioMedicine 51 102520-102520. .
-
Prieto, I; Alarcon, CR; Garcia-Gomez, R; Berdun, R; Urgel, T; Portero, M; Pamplona, R; Martinez-Ruiz, A; Ruiz-Sanz, JI; Ruiz-Larrea, MB; Jove, M; Cerdan, S; Monsalve, M
Metabolic adaptations in spontaneously immortalized PGC-1a knock-out mouse embryonic fibroblasts increase their oncogenic potential.
Redox Biology 29 101396-101396. .
-
Sanchez, E; Lecube, A; Betriu À; Hernandez, C; Lopez-Cano, C; Gutierrez-Carrasquilla, L; Kerkeni, M; Yeramian, A; Purroy, F; Pamplona, R; Farràs C; Fernandez, E; Barbe, F; Simo, R; ILERVAS project; Hernández M; Rius F; Polanco D; de la Torre MS; Torres G; Godoy P; Portero-Otin M; Jové M; Colàs-Compàs L; Benabdelhak I; Miquel E; Ortega M; Valdivielso JM; Bermúdez M; Martínez-Alonso M
Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The MR-1 ILERVAS Project
Diabetes & metabolism 45 595-598. .
-
Gubina, N; Naudi, A; Stefanatos, R; Jove, M; Scialo, F; Fernandez-Ayala, DJ; Rantapero, T; Yurkevych, I; Portero-Otin, M; Nykter, M; Lushchak, O; Navas, P; Pamplona, R; Sanz, A
Essential Physiological Differences Characterize Short- and Long-Lived Strains of Drosophila melanogaster
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES 74 1835-1843. .
-
Pamplona, R; Borras, C; Jove, M; Pradas, I; Ferrer, I; Viña J
Redox lipidomics to better understand brain aging and function
FREE RADICAL BIOLOGY AND MEDICINE 144 310-321. .
-
Sánchez E; Betriu À; López-Cano C; Hernández M; Fernández E; Purroy F; Bermúdez-López M; Farràs-Sallés C; Barril S; Pamplona R; Rius F; Hernández C; Simó R; Lecube A
Characteristics of atheromatosis in the prediabetes stage: a cross-sectional investigation of the ILERVAS project
Cardiovascular Diabetology 18 154-154. .
-
Pradas, I; Jove, M; Cabre, R; Ayala, V; Mota-Martorell, N; Pamplona, R
Effects of Aging and Methionine Restriction on Rat Kidney Metabolome
Metabolites 9 -. .
-
Pradas, I; Rovira-Llopis, S; Naudi, A; Bañuls C; Rocha, M; Hernandez-Mijares, A; Pamplona, R; Victor, VM; Jove, M
Metformin induces lipid changes on sphingolipid species and oxidized lipids in polycystic ovary syndrome women
SCIENTIFIC REPORTS 9 16033-16033. .
-
Bahhir, D; Yalgin, C; Ots, L; Järvinen S; George, J; Naudi, A; Krama, T; Krams, I; Tamm, M; Andjelkovic, A; Dufour, E; González de Cózar JM; Gerards, M; Parhiala, M; Pamplona, R; Jacobs, HT; Jõers P
Manipulating mtDNA in vivo reprograms metabolism via novel response mechanisms
Plos Genetics 15 -. .
-
Casasnovas, C; Ruiz, M; Schlüter A; Naud?, A; Fourcade, S; Veciana, M; Casta?er, S; Albert?, A; Bargall?, N; Johnson, M; Raymond, GV; Fatemi, A; Moser, AB; Villarroya, F; Portero-Ot?n, M; Artuch, R; Pamplona, R; Pujol, A
Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study
NEUROTHERAPEUTICS 16 1167-1182. .
Projectes
- Metabolismo de eter lípidos y envejecimiento humano
- La vía de señalización mediada por los lípidos bioactivos diacilglicerol-ácido fosfatídico como biomarcadores para discriminar los estadios iniciales de la enfermedad de Alzheimer del envejecimiento normal
- Identification of compounds for inhibition of ACE2 membrane expression
- Dynamics of the neuronal, metabolomic and neuropsychological signatures underlying the adptations for motherhood during pregnancy. (babybrain)
- Neurolipidómica del envejecimiento cerebral humano
- "Imagenoma de l'Envelliment": Estudi observacional poblacional per definir biomarcadors d'imatge RM corporal integral i òmics que s'associen al procés d'envelliment i a factors de risc biopsicosocial en subjectes adults i que defineixen la seva trajectòria vital cap a un envelliment saludable o bé la fragilitat i discapacitat.
- IDENTIFYING PREDICTORS OF CARDIOVASCULAR EVENTS IN CHRONIC KIDNEY DISEASE. A COHORTS SUBSTUDY WITHIN THE NEFRONA STUDY
- Interactomas y marcadores para discriminar factores de vulnerabilidad neuronal regional en la neurodegeneración asociada al envejecimiento normal y patológico en el SNC
- IDENTIFICACION DE BIOMARCADORES LIPIDICOS EN LIQUIDO CEFALORRAQUIDEO COMO PREDICTORES DEL DESARROLLO DE LA ENFERMEDAD DE ALZHEIMER EN PACIENTES CON DETERIORO COGNITIVO LEVE
- ESTRES OXIDATIVO E INFLAMACION EN LA EVOLUCION DEL PROCESO DE ENVEJECIMIENTO Y PROGRESION DE LA ENFERMEDAD DE ALZHEIMER EN DIFERENTES REGIONES DEL SISTEMA NERVIOSO CENTRAL HUMANO
- PEGASO - Personalised Guidance Services for Optimising lifesstyle in teenagers through awareness, motivation and engagement
- CONVOCATORIA D'AJUTS PER A PERSONAL PREDOCTORAL DEL IRBLLEIDA "FUNDACIO LA CAIXA"
